Latest News and Press Releases

PORTLAND, OR--(Marketwire - Oct 24, 2012) -  MolecularMD Corp. announced today that presentations pertaining to clinical validation of Next Generation Sequencing platforms and advances in...

PORTLAND, OR--(Marketwire - Jul 30, 2012) -  MolecularMD Corp. today announced that it has submitted its application for Premarket Approval (PMA) of the MolecularMD BCR-ABL T315I Mutation Test...

PORTLAND, OR--(Marketwire - Apr 2, 2012) - MolecularMD Corp. announces that it has closed a $6 Million Series B equity financing led by existing investor, Ballast Point Ventures, which is joined by...

PORTLAND, OR--(Marketwire - Dec 9, 2011) - MolecularMD Corp. today announces the issuance of a patent titled "Methods and Compositions for Detecting a Drug Resistant EGFR Mutant." The newly issued...

PORTLAND, OR--(Marketwire - October 18, 2010) - MolecularMD Corp. announced today that it has entered into a licensing agreement with New York University (NYU) and Memorial Sloan-Kettering Cancer...

PORTLAND, OR--(Marketwire - October 28, 2009) - MolecularMD Corp announced today that it has moved their core operations to a expanded dedicated facility with capacity and functionality to support...